This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Laurin Melzig, PhD
Director R&D Process Development at Bachem AG
Speaker

Profile

Laurin Melzig completed his graduate studies at the Ludwig Maximilian University, Munich, Germany. After his PhD Dissertation in organometallic chemistry with Prof. Knochel in 2011, he went on to do a PostDoc in medicinal chemistry at the Istituto Italiano di Tecnologia, Genova, Italy from 2011 to 2014. He then joined Bachem in 2014, where he acts as Director R&D and Process Development since 2022

Agenda Sessions

  • Risk Assessment for Nitrosamine Contamination in Peptide APIs

    4:15pm